Hyundai vs Roche: Founders, CEOs and History
Hyundai was founded in 1967 by Chung Ju-yung and is led by Jose Munoz. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.
Company facts
Founders
Hyundai
Chung Ju-yung
Chung Ju-yung was a South Korean industrialist and the founder of the Hyundai group. He left the poor farming village where he grew up and in 1947 started a small civil engineering company.
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
CEOs and their tenures
Hyundai
- Chung Eui-sun2019–present
Executive Chair, Hyundai Motor Group (former co-CEO of Hyundai Motor)
He successfully elevated Hyundai and Kia from budget alternatives into highly desirable, premium-leaning brands, capturing significant global EV market share.
Source - Jaehoon Chang2021–2024
President and Chief Executive Officer
As co-CEO, he drove record-breaking operating profits in 2023 by prioritizing high-margin SUVs and luxury Genesis models amid global supply chain shortages.
Source - Jose Munoz2025–present
President and Chief Executive Officer
Munoz ran Hyundai's North American business and served as global COO before becoming CEO. Since 2025 he has led the response to U.S. tariffs, the $26 billion U.S. investment plan through 2028, the hybrid expansion and the 2030 target of 5.55 million sales.
Source
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Timeline: Hyundai and Roche side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1967Hyundai
Hyundai Motor Company Founded
Chung Ju-yung established Hyundai Motor Company, creating the automotive arm that would become the flagship of South Korea's car industry.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
1975Hyundai
Hyundai Pony
The Hyundai Pony became Korea's first mass-produced passenger car and gave Hyundai a domestic platform for exports and engineering learning.
1986Hyundai
U.S. Market Entry
Hyundai entered the U.S. market with the Excel, rapidly building awareness as a value-oriented global automaker.
1998Hyundai
Kia Stake Acquired
Hyundai acquired a controlling stake in Kia during the Asian financial crisis, creating the basis for Hyundai Motor Group's modern platform scale.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2015Hyundai
Genesis Luxury Brand
Hyundai launched Genesis as a standalone luxury brand, supporting premiumization and higher-margin global growth.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2020Hyundai
E-GMP EV Platform
Hyundai introduced its dedicated E-GMP electric-vehicle platform, giving models such as Ioniq 5 and Ioniq 6 fast-charging and packaging advantages.
2021Hyundai
Boston Dynamics Acquisition
Hyundai Motor Group acquired a controlling stake in Boston Dynamics, adding robotics to its long-term mobility and automation strategy.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2025Hyundai
Jose Munoz Becomes CEO
Jose Munoz, previously Hyundai's global COO and head of its North American business, became President and CEO effective January 1, 2025, succeeding Jaehoon Chang. He is the first non-Korean to lead the company.
2025Hyundai
Record Revenue, Tariff-Hit Profit
Hyundai reported FY2025 revenue of ~$132 billion (KRW 186.25 trillion), up 6.3%, while operating profit fell 19.5% to ~$8.14 billion (KRW 11.47 trillion) and net profit fell 21.7% to ~$7.36 billion (KRW 10.36 trillion), largely due to U.S. tariffs.
2025Hyundai
Georgia Battery Plant Raid
In September 2025, U.S. immigration agents detained hundreds of workers, many of them Korean, at the Hyundai-LG Energy Solution battery plant under construction in Georgia, delaying its opening by months.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2026Hyundai
Full Ownership of Boston Dynamics
In July 2026 Hyundai Motor Group moved to buy SoftBank's remaining stake in Boston Dynamics, a deal reported at about $325 million, making the robotics company wholly owned.
2026Hyundai
2026 CEO Investor Day
At its August 2026 CEO Investor Day, Hyundai reaffirmed a 2030 target of 5.55 million global sales and detailed its $26 billion U.S. investment plan through 2028.
Acquisitions
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Questions about Hyundai vs Roche
Who is the CEO of Hyundai Motor Company and F. Hoffmann-La Roche AG?
Hyundai Motor Company is led by Jose Munoz and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Hyundai Motor Company founded vs F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG was founded in 1896 — 71 years before Hyundai Motor Company, which was founded in 1967. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Hyundai Motor Company.
How many employees does Hyundai Motor Company have compared to F. Hoffmann-La Roche AG?
Hyundai Motor Company employs approximately 123,000 people, while F. Hoffmann-La Roche AG employs approximately 112,774. Hyundai Motor Company has the larger workforce at 123,000 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Hyundai Motor Company and F. Hoffmann-La Roche AG headquartered?
Hyundai Motor Company is headquartered in South Korea and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Hyundai Motor Company and F. Hoffmann-La Roche AG?
Hyundai Motor Company was founded by Chung Ju-yung. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.
Which company has a longer operating history — Hyundai Motor Company or F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Hyundai Motor Company has been in operation for around 59 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Hyundai vs Roche overview